The Latest Analyst Ratings for HealthEquity
Portfolio Pulse from Benzinga Insights
In the last quarter, HealthEquity (NASDAQ:HQY) received 1 bullish and 3 somewhat bullish analyst ratings. The average 12-month price target for the company is $76.0, with a high of $80.00 and a low of $69.00, representing a 5.56% increase from the previous average of $72.00.
June 01, 2023 | 9:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HealthEquity received 1 bullish and 3 somewhat bullish analyst ratings in the last quarter. The average 12-month price target is $76.0, up 5.56% from the previous average.
The positive analyst ratings and the increase in the average 12-month price target suggest that HealthEquity's stock price is likely to go up in the short term. The 5.56% increase in the average price target indicates that analysts have a positive outlook on the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100